Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMBITION-cm for HIV-associated cryptococcal meningitis
ISRCTN10248064Phase 3Completed
- Sponsor
- St George's, University of London
- Start
- Nov 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
01
Overview
Phase 3, randomised, open-label trial of amphotericin b, amphotericin b deoxycholate, fluconazole and flucytosine in cryptococcal meningitis and human immunodeficiency virus infection (HIV), sponsored by St George's, University of London. Started Nov 2014; status: completed.
02
Drugs
amphotericin bamphotericin b deoxycholatefluconazoleflucytosine
03
Conditions
cryptococcal meningitishuman immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on ISRCTN10248064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN10248064.